The Effects of Vitamin D on muscle function in patients with diabetic peripheral neuropathy

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023079

Enrollment

Unknown

Registered

2019-05-10

Start date

2019-05-09

Completion date

Unknown

Last updated

2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic peripheral neuropathy

Interventions

experimental group:vitamin D3 orally+conventional therapy

control group:conventional therapy

Eligibility

Sex/Gender

All

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1)The patients with DPN aged 30-70 years;(2) vitamin D insufficient.

Exclusion criteria

Exclusion criteria: (1)Severe heart failure, cerebrovascular disease, etc.; (2) acute and chronic infections and infectious diseases; (3) patients with hypercalcemia, parathyroid diseases and malignant tumors; (4) taking drugs that may affect the metabolism of vitamin D; (5) have taken calcium or vitamin D drugs in the past 6 months; (6) pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
25 hydroxyvitamin D;bioelectrica l im pedance analysis;	—

Countries

China

Contacts

Public ContactZhou Jingying

Chongqing Shapingba District People's Hospital

zhoujy1149@163.com+86 13667661267

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026